The stock market performance of Avidity Biosciences Inc has been very steady. Over the last year, the company’s stock hit its highest at $48.80 on 07/29/24, while the lowest price during the same time frame was $4.82, recorded on 10/31/23.
52-week price history of RNA Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Avidity Biosciences Inc’s current trading price is -9.46% away from its 52-week high, while its distance from the 52-week low is 815.73%. The stock’s price range for this period has remained between $4.82 and $48.80. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.27 million for the day, which was noticeably lower compared to the shares’ average daily volume of 1.42 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Avidity Biosciences Inc (RNA) has experienced a quarterly rise of 15.27% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.17B and boasts a workforce of 253 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 37.61, with a change in price of +20.66. Similarly, Avidity Biosciences Inc recorded 1,425,127 in trading volume during the last 100 days, posting a change of +86.72%.
RNA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RNA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
RNA Stock Stochastic Average
As of today, the raw stochastic average of Avidity Biosciences Inc over the last 50 days is at 63.39%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 77.37%. Further, the company’s Stochastic %K and %D values for the last 20 days were 52.05% and 41.27%, respectively.
RNA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 388.22%.However, over the last six months, we can see a weaker performance of 85.73%. Over the last 30 days, the price of RNA has leaped by -2.68%. And in the last five days, it has surged by 8.99%.
